Lido Advisors, LLC Charles River Laboratories International, Inc. Transaction History

Lido Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $151,668 - $224,683	-743 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$255.51 - $362.11 $15,841 - $22,450	-62 Reduced 7.7%	743 $210,000
Q4 2021 Feb 15, 2022	BUY	$351.38 - $448.68 $14,055 - $17,947	40 Added 5.23%	805 $303,000
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $30,929 - $38,038	-83 Reduced 9.79%	765 $316,000
Q2 2021 Aug 12, 2021	BUY	$294.17 - $371.65 $294 - $371	1 Added 0.12%	848 $314,000
Q1 2021 May 13, 2021	BUY	$249.67 - $299.48 $6,241 - $7,487	25 Added 3.04%	847 $245,000
Q4 2020 Feb 08, 2021	BUY	$222.0 - $252.62 $182,484 - $207,653	822 New	822 $205,000

696

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.47B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lido Advisors, LLC with notifications on news.